Abstract:Previously, we showed that the presence of the herpes simplex virus 1 (HSV-1) gD glycoprotein but not gB potently restricted HIV-1 particle infectivity. This restriction was characterized by incorporation of HSV-1 gD and the exclusion of HIV-1 gp120/gp41 from budding virus particles. To determine the structural domains involved in gD restriction of HIV-1, a series of deletion mutants and chimeric proteins involving combinations between gD and the nonrestrictive gB were generated. Our results show that deletion of the cytoplasmic tail domain (CTD) of gD or replacement of the transmembrane domain (TMD) with the TMD from gB slightly reduced restriction activity. However, replacement of the gD CTD with that of gB resulted in lower cell surface expression, significantly less incorporation into HIV-1 particles, and inefficient restriction of the release of infectious HIV-1. Analysis of gB/gD chimeric proteins revealed that removal of the gB CTD or replacement with gD CTD resulted in enhanced surface expression and an increase in restriction activity. Finally, we show that expression of gD without other HSV-1 proteins resulted in gD fractionation into detergent-resistant membranes (DRM) and that gD colocalized with the raft marker GM1, which may partially explain its incorporation into budding virus particles. Taken together, our results suggest that expression of gD at the cell surface is likely a major factor, but other intrinsic properties are also involved in the gD-mediated restriction of HIV-1 particle infectivity. IMPORTANCE Previously, we showed that the presence of the gD glycoprotein in virus producer cells but not gB potently restricted HIV-1 particle infectivity. To better understand the relationship between cell surface expression, virus incorporation, and restriction of HIV-1, we analyzed a series of deletion mutants and chimeric proteins in which domains of gD and gB were swapped. Our results indicate that (i) gD/gB chimeras having the cytoplasmic domain (CTD) of gB significantly reduced cell surface expression, release from cells, incorporation into virus, and reduced HIV-1 restriction, (ii) removal of the gB CTD or replacement with the gD CTD resulted in better surface expression, incorporation into HIV-1, and enhanced restriction, and (iii) the transmembrane domain of gB can influence transport and ultimately effect incorporation of gB into HIV-1. Overall, these data support a role for gD surface expression as crucial to restriction of infectious HIV-1 release.

GB Virus Type C E2 Protein Inhibits Human Immunodeficiency Virus Type 1 Gag Assembly by Downregulating Human ADP-ribosylation Factor 1.

USP49 Potently Stabilizes APOBEC3G Protein by Removing Ubiquitin and Inhibits HIV-1 Replication

Correction: HIV-1 Fusion is Blocked Through Binding of GB Virus C E2D Peptides to the HIV-1 Gp41 Disulfide Loop.

Inhibition of HIV-1 assembly by coiled-coil domain containing protein 8 in human cells

RNA Interference Effectively Degrades Mrna and Inhibits Protein Expression of GBV-C E2 Gene in Huh7 Cells

Guanylate-Binding Protein 1 Inhibits Nuclear Delivery of Kaposi's Sarcoma-Associated Herpesvirus Virions by Disrupting Formation of Actin Filament

Overexpressed Coiled-Coil Domain Containing Protein 8 (CCDC8) Mediates Newly Synthesized HIV-1 Gag Lysosomal Degradation

Human HERC5 Restricts an Early Stage of HIV-1 Assembly by a Mechanism Correlating with the ISGylation of Gag

Gb Virus C Infection is Associated with a Reduced Rate of Reactivation of Latent HIV and Protection against Activation-Induced T-Cell Death

Antiviral Inhibition Of The Hiv-1 Capsid Protein

Guanylate-binding Protein 1 Inhibits Nuclear Delivery of Pseudorabies Virus by Disrupting Structure of Actin Filaments

PSGL-1 Inhibits HIV-1 Infection by Restricting Actin Dynamics and Sequestering HIV Envelope Proteins

Structural Domains of the Herpes Simplex Virus 1 gD Protein That Restrict Human Immunodeficiency Virus Particle Infectivity

Host Restriction Factor A3G Inhibits the Replication of Enterovirus D68 by Competitively Binding the 5′ Untranslated Region with PCBP1

Structural and Functional Study of Apoptosis-linked Gene-2·Heme-binding Protein 2 Interactions in HIV-1 Production.

Interaction of the Human Immunodeficiency Virus Type 1 Nucleocapsid with Actin

Guanylate-binding protein 5 antagonizes viral glycoproteins independently of furin processing

Gb Virus C (Gbv-C) Infection in Hepatitis C Virus (Hcv)/hiv-Coinfected Patients Receiving Hcv Treatment: Importance of the Gbv-C Genotype

Vif-CBFβ Interaction is Essential for Vif-induced Cell Cycle Arrest.

Cleavage of Grb2-Associated Binding Protein 2 by Viral Proteinase 2A During Coxsackievirus Infection